31 – 39 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2015
-
Mark
Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
(
- Contribution to journal › Article
-
Mark
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
(
- Contribution to journal › Article
-
Mark
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.
(
- Contribution to journal › Article
- 2013
-
Mark
Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study
2013) In Mediators of Inflammation(
- Contribution to journal › Article
-
Mark
Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
(
- Contribution to journal › Article
-
Mark
Association of Genes in the NF-kappa B Pathway with Antibody-Positive Primary Sjogren's Syndrome
(
- Contribution to journal › Article
-
Mark
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome
(
- Contribution to journal › Article
- 2012
-
Mark
Vertebral Fractures in Ankylosing Spondylitis Are Associated with Lower Bone Mineral Density in Both Central and Peripheral Skeleton.
(
- Contribution to journal › Article
-
Mark
Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »